logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
O

Oktay Bozkurt

erciyes university medical school
H指数:15
被引数:593

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients

比较固定剂量与体重基础剂量纳武利尤单抗治疗非小细胞肺癌患者的疗效

Scientific Reports
IF3.9
2026-05-080
OAAI
Muhammet Cengiz; Oktay Bozkurt; Ayse Nuransoy Cengiz; Deniz Can Guven; Elif Sahin; Emel Mutlu Ozkan; Mustafa Ersoy; Ezgi Turkoğlu; Sedat Yildirim; Erdem Kolemen; Beyza Unlu; Hayati Arvas; Mehmet Mutlu Kidi; Sedat Biter; Latif Karahan; Mustafa Erman; Ismail Oguz Kara; Meltem Baykara; Pervin Can Sanci; Anıl Karakayali; Umut Kefeli; Devrim Cabuk; Saadettin Kilickap; Teoman Sakalar; Nargiz Majidova; Berrak Mermit Ercek; Muslih Urun; Gözde Agdas; Duygu Bayir; Cengiz Akosman; Erkam Kocaaslan; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas; Mevlude Inanc; Metin Ozkan
Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab

苏格兰炎症预后评分在经二线纳武利尤单抗治疗的晚期NSCLC中的预后价值

Discover Oncology
IF2.9
2026-04-210
OAAI
Erdem Kolemen; Kazım Uygun; Devrim Çabuk; Mustafa Erman; Saadettin Kılıçkap; Tolga Köseci; Duygu Bayır; Oktay Bozkurt; Deniz Can Güven; Hacer Demir; Muslih Urun; Sedat Yıldız; Teoman Sakalar; Nargiz Majidova; Emel Mutlu Özkan; Cengiz Akosman; Muhammet Cengiz; Mustafa Ersoy; Elif Şahin; Pervin Can Sancı; Ayşe Nuransoy Cengiz; Gözde Ağdaş; Erkam Kocaaslan; Ezgi Türkoğlu; Sedat Yıldırım; Berrak Mermit Erçek; Anıl Karakayalı; Hayati Arvas; Mehmet Mutlu Kıdı; Sedat Biter; Havva Yeşil Cinkir; Latif Karahan; Aslıhan Ezgi Apaydın Rollas; Umut Kefeli
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab

基线维生素D状态及接受纳武利尤单抗治疗的晚期非小细胞肺癌患者的临床结局

Scientific Reports
IF3.9
2026-04-140
OAAI
Gözde Ağdaş; Duygu Bayir; Elif Şahin; Muhammet Cengiz; Deniz Can Güven; Mehmet Salim Demir; Ertuğrul Bayram; Duygu Özaşkın; Meltem Baykara; Oktay Bozkurt; Mevlüde İnanç; Metin Özkan; Ayşe Nuransoy Cengiz; Mustafa Erman; Umut Kefeli; Emel Mutlu Özkan; Erkam Kocaaslan; Devrim Çabuk; Saadettin Kiliçkap; Pervin Can Sanci; Muslih Urun; Teoman Sakalar; Cengiz Akosman; Erdem Kolemen; Ezgi Turkoğlu; Anıl Karakayali; Mustafa Ersoy; Sedat Yildirim; Latif Karahan; Hayati Arvas; Mehmet Mutlu Kidi; Sedat Biter; Berrak Mermit Ercek; Nargiz Majidova; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas; İbrahim Karadağ
The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer

接受免疫疗法治疗的晚期肺癌患者中，早期肺部免疫预后指数变化的预后意义

Discover Oncology
IF2.9
2026-02-210
OAAI
Muhammet Cengiz; Oktay Bozkurt; Ayşe Nuransoy Cengiz; Mevlude Inanc; Metin Ozkan; Emel Mutlu Ozkan; Deniz Can Guven; Mustafa Erman; Latif Karahan; Elif Sahin; Anıl Karakayali; Pervin Can Sanci; Umut Kefeli; Devrim Cabuk; Erdem Kolemen; Mehmet Mutlu Kidi; Sedat Biter; Tolga Koseci; Muslih Urun; Berrak Mermit Ercek; Duygu Bayir; Gözde Agdas; Teoman Sakalar; Nargiz Majidova; Sedat Yildiz; Hacer Demir; Cengiz Akosman; Mustafa Ersoy; Saadettin Kilickap; Erkam Kocaaslan; Ezgi Turkoğlu; Sedat Yildirim; Hayati Arvas; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas
Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study
ANNALS OF ONCOLOGY
IF65.4
2022-06-011
OAAI
Artac, M.; Cubukcu, E.; Bozkurt, O.; Bilici, A.; Celik, S.; Ozcelik, M.; Oven, B.; Simsek, E.; Geredeli, C.; Karaca, M.; Cil, T.; Harputluoglu, H.; Sendur, M.; Turk, H.; Kefeli, U.; Alacacioglu, A.; Tural, D.; Sakin, A.; Karadurmus, N.; Cevik, D.; Dane, F.; Gumus, M.

研究方向

暂未获取到该数据
M
Metin Özkan
H 指数:20论文数:185被引数:1,327
M
Mevlüde İnanç
H 指数:13论文数:79被引数:666
U
Umut Kefeli
H 指数:17论文数:95被引数:1,083
E
Emel Mutlu
H 指数:7论文数:28被引数:131
M
Muhammet Cengiz
H 指数:2论文数:14被引数:11
A
Ayşe Nuransoy Cengi̇z
H 指数:3论文数:21被引数:81
T
Teoman Şakalar
H 指数:9论文数:125被引数:298
E
Erkam Kocaaslan
H 指数:3论文数:43被引数:30
H
Hayati Arvas
H 指数:3论文数:20被引数:22
S
Sedat Biter
H 指数:4论文数:47被引数:38